LymphedemaV1, PubMed, Corpus, bibRecord, 000984

Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.

Identifieur interne : 000984 ( PubMed/Corpus ); précédent : 000983; suivant : 000985

Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.

Auteurs : Luca G. Campana ; Sara Valpione ; Annalisa Tosi ; Marco Rastrelli ; Carlo R. Rossi ; Camillo Aliberti

Source :

Journal of vascular and interventional radiology : JVIR [ 1535-7732 ] ; 2016.

RBID : pubmed:26916941

English descriptors

KwdEn :
- Antineoplastic Agents (administration & dosage), Bleomycin (administration & dosage), Electrochemotherapy, Female, Hemangiosarcoma (diagnosis), Hemangiosarcoma (pathology), Hemangiosarcoma (therapy), Humans, Lymphangiosarcoma (diagnosis), Lymphangiosarcoma (pathology), Lymphangiosarcoma (therapy), Melphalan (administration & dosage), Middle Aged, Neoplasm Recurrence, Local, Perfusion (methods), Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha (administration & dosage).
MESH :
- chemical , administration & dosage : Antineoplastic Agents, Bleomycin, Melphalan, Tumor Necrosis Factor-alpha.
- diagnosis : Hemangiosarcoma, Lymphangiosarcoma.
- methods : Perfusion.
- pathology : Hemangiosarcoma, Lymphangiosarcoma.
- therapy : Hemangiosarcoma, Lymphangiosarcoma.
- Electrochemotherapy, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Time Factors, Treatment Outcome.

DOI: 10.1016/j.jvir.2015.11.060
PubMed: 26916941

Links to Exploration step

pubmed:26916941

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.</title>
<author><name sortKey="Campana, Luca G" sort="Campana, Luca G" uniqKey="Campana L" first="Luca G" last="Campana">Luca G. Campana</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valpione, Sara" sort="Valpione, Sara" uniqKey="Valpione S" first="Sara" last="Valpione">Sara Valpione</name>
<affiliation><nlm:affiliation>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tosi, Annalisa" sort="Tosi, Annalisa" uniqKey="Tosi A" first="Annalisa" last="Tosi">Annalisa Tosi</name>
<affiliation><nlm:affiliation>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rastrelli, Marco" sort="Rastrelli, Marco" uniqKey="Rastrelli M" first="Marco" last="Rastrelli">Marco Rastrelli</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rossi, Carlo R" sort="Rossi, Carlo R" uniqKey="Rossi C" first="Carlo R" last="Rossi">Carlo R. Rossi</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aliberti, Camillo" sort="Aliberti, Camillo" uniqKey="Aliberti C" first="Camillo" last="Aliberti">Camillo Aliberti</name>
<affiliation><nlm:affiliation>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26916941</idno>
<idno type="pmid">26916941</idno>
<idno type="doi">10.1016/j.jvir.2015.11.060</idno>
<idno type="wicri:Area/PubMed/Corpus">000984</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000984</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.</title>
<author><name sortKey="Campana, Luca G" sort="Campana, Luca G" uniqKey="Campana L" first="Luca G" last="Campana">Luca G. Campana</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valpione, Sara" sort="Valpione, Sara" uniqKey="Valpione S" first="Sara" last="Valpione">Sara Valpione</name>
<affiliation><nlm:affiliation>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tosi, Annalisa" sort="Tosi, Annalisa" uniqKey="Tosi A" first="Annalisa" last="Tosi">Annalisa Tosi</name>
<affiliation><nlm:affiliation>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rastrelli, Marco" sort="Rastrelli, Marco" uniqKey="Rastrelli M" first="Marco" last="Rastrelli">Marco Rastrelli</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Rossi, Carlo R" sort="Rossi, Carlo R" uniqKey="Rossi C" first="Carlo R" last="Rossi">Carlo R. Rossi</name>
<affiliation><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aliberti, Camillo" sort="Aliberti, Camillo" uniqKey="Aliberti C" first="Camillo" last="Aliberti">Camillo Aliberti</name>
<affiliation><nlm:affiliation>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of vascular and interventional radiology : JVIR</title>
<idno type="eISSN">1535-7732</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (administration & dosage)</term>
<term>Bleomycin (administration & dosage)</term>
<term>Electrochemotherapy</term>
<term>Female</term>
<term>Hemangiosarcoma (diagnosis)</term>
<term>Hemangiosarcoma (pathology)</term>
<term>Hemangiosarcoma (therapy)</term>
<term>Humans</term>
<term>Lymphangiosarcoma (diagnosis)</term>
<term>Lymphangiosarcoma (pathology)</term>
<term>Lymphangiosarcoma (therapy)</term>
<term>Melphalan (administration & dosage)</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Perfusion (methods)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Tumor Necrosis Factor-alpha (administration & dosage)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antineoplastic Agents</term>
<term>Bleomycin</term>
<term>Melphalan</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Perfusion</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Electrochemotherapy</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26916941</PMID>
<DateCreated><Year>2016</Year>
<Month>02</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>12</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-7732</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>3</Issue>
<PubDate><Year>2016</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Journal of vascular and interventional radiology : JVIR</Title>
<ISOAbbreviation>J Vasc Interv Radiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.</ArticleTitle>
<Pagination><MedlinePgn>444-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvir.2015.11.060</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1051-0443(15)01187-2</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campana</LastName>
<ForeName>Luca G</ForeName>
<Initials>LG</Initials>
<AffiliationInfo><Affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Valpione</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tosi</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rastrelli</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rossi</LastName>
<ForeName>Carlo R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo><Affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aliberti</LastName>
<ForeName>Camillo</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Vasc Interv Radiol</MedlineTA>
<NlmUniqueID>9203369</NlmUniqueID>
<ISSNLinking>1051-0443</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>11056-06-7</RegistryNumber>
<NameOfSubstance UI="D001761">Bleomycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Q41OR9510P</RegistryNumber>
<NameOfSubstance UI="D008558">Melphalan</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C537491">Stewart Treves syndrome</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001761" MajorTopicYN="N">Bleomycin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053672" MajorTopicYN="Y">Electrochemotherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006394" MajorTopicYN="N">Hemangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008204" MajorTopicYN="N">Lymphangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008558" MajorTopicYN="N">Melphalan</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>09</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26916941</ArticleId>
<ArticleId IdType="pii">S1051-0443(15)01187-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.jvir.2015.11.060</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000984 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000984 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26916941
   |texte=   Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26916941" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.

Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki